These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12893407)

  • 41. Interferon-alpha induced psoriasis in a teenager.
    Mendieta KL; Irfan M; Fernandez Faith E
    Pediatr Dermatol; 2018 Mar; 35(2):e136-e137. PubMed ID: 29575077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Secondary hemophagocytic syndrome due to Peg-interferon administration].
    Ruiz Ramos J
    Farm Hosp; 2014 Jan; 38(1):73-4. PubMed ID: 24483865
    [No Abstract]   [Full Text] [Related]  

  • 43. [Interferon therapy for hepatitis B and C].
    Iino S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():559-63. PubMed ID: 17455681
    [No Abstract]   [Full Text] [Related]  

  • 44. Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy.
    Bettoli V; Mantovani L; Boccia S; Virgili A
    Acta Derm Venereol; 2006; 86(3):258-9. PubMed ID: 16710591
    [No Abstract]   [Full Text] [Related]  

  • 45. Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy.
    Navinés R; Castellví P; Solà R; Martín-Santos R
    Gen Hosp Psychiatry; 2008; 30(4):387-9. PubMed ID: 18585548
    [No Abstract]   [Full Text] [Related]  

  • 46. Simultaneous occurrence of pleural effusion and interstitial pneumonitis after treatment with pegylated interferon for hepatitis C virus infection.
    Ji F; Li Z; Xue H; Liu L; Deng H
    South Med J; 2011 Feb; 104(2):140-2. PubMed ID: 21206334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin.
    Guilabert A; Bosch X; Julià M; Iranzo P; Mascaró JM
    Br J Dermatol; 2005 Feb; 152(2):377-9. PubMed ID: 15727663
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
    Sprenger R; Sagmeister M; Offner F
    Gut; 2005 Mar; 54(3):438-9; author reply 439. PubMed ID: 15710996
    [No Abstract]   [Full Text] [Related]  

  • 49. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin.
    Bongiovanni M; Ranieri R; Ferrero S; Casanova F; Monforte Ad
    AIDS; 2006 Oct; 20(15):1989-90. PubMed ID: 16988527
    [No Abstract]   [Full Text] [Related]  

  • 50. Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients.
    Teta D; Lüscher BL; Gonvers JJ; Francioli P; Phan O; Burnier M
    Nephrol Dial Transplant; 2005 May; 20(5):991-3. PubMed ID: 15741205
    [No Abstract]   [Full Text] [Related]  

  • 51. Safety, tolerability, and efficacy of pegylated-interferon alfa-2a plus ribavirin in HCV-related decompensated cirrhotics.
    Tekin F; Gunsar F; Karasu Z; Akarca U; Ersoz G
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1081-5. PubMed ID: 18346186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.
    Venezia G; Licata A; Di Marco V; Craxì A; Almasio PL
    Dig Liver Dis; 2005 Nov; 37(11):882-5. PubMed ID: 16169301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute psychosis after injection of pegylated interferon alpha-2a.
    Thome J; Knopf U
    Eur Psychiatry; 2003 May; 18(3):142-3. PubMed ID: 12763304
    [No Abstract]   [Full Text] [Related]  

  • 54. Pancreatitis induced by pegylated interferon alfa-2b in a patient affected by chronic hepatitis C.
    Cecchi E; Forte P; Cini E; Banchelli G; Ferlito C; Mugelli A
    Emerg Med Australas; 2004; 16(5-6):473-5. PubMed ID: 15537413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials.
    Chou R; Carson S; Chan BK
    J Viral Hepat; 2008 Aug; 15(8):551-70. PubMed ID: 18482285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Movement and extrapyramidal disorders associated with interferon use in HIV/hepatitis C coinfection.
    Brito MO; Doyle T
    AIDS; 2007 Sep; 21(14):1987-9. PubMed ID: 17721114
    [No Abstract]   [Full Text] [Related]  

  • 57. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ulcerative colitis triggered by pegylated interferon alone therapy for chronic hepatitis C.
    Altınbas A; Koybasıoglu F; Aktas E; Yılmaz B; Coban S
    Inflamm Bowel Dis; 2011 Apr; 17(4):1050. PubMed ID: 20623698
    [No Abstract]   [Full Text] [Related]  

  • 59. [Adverse effects of combining polyethylene glycol interferon with ribavilin on hepatitis C patients].
    Si CW
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):686-7. PubMed ID: 14636449
    [No Abstract]   [Full Text] [Related]  

  • 60. Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
    Quarantini LC; Bressan RA; Galvão A; Batista-Neves S; Paraná R; Miranda-Scippa A
    Liver Int; 2007 Oct; 27(8):1098-102. PubMed ID: 17845538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.